Cell Therapy Moves Forward Across the Pipeline
Beta cell replacement therapies aim to overcome the obstacles to realize their potential, but several approaches are making them a…
Who is at risk for type 1 diabetes?
Although its exact causes are unknown, researchers have uncovered type 1 diabetes (T1D) risk factors that increase a person's likelihood…
“Know you are making a difference.” More Words of Wisdom from Past Breakthrough T1D Children’s Congress Delegates
More of our past Breakthrough T1D Children’s Congress Delegates share advice with the newly selected 2023 Delegates.
Meet Natalie Stanback: Breakthrough T1D 2023 Children’s Congress Chair
She knows T1D; she knows Advocacy—and she knows how to get things done on Capitol Hill! Meet the Breakthrough T1D…
“Together we are unstoppable.” Words of Wisdom from Past Breakthrough T1D Children’s Congress Delegates
Our past Breakthrough T1D Children’s Congress Delegates share advice with the newly selected 2023 Delegates.
Improving Lives Through Clinical Trials
Pharmacist Marjorie Lazarre has seen the life-changing outcomes of type 1 diabetes (T1D) research and is confident clinical trials are…
Verapamil Slows Type 1 Diabetes Progression in Newly Diagnosed Children and Teens
The CLVer study found that newly diagnosed individuals on verapamil were making more insulin one year after diagnosis than those…
Is there a cure for type 1 diabetes?
There is currently no cure for type 1 diabetes (T1D), but Breakthrough T1D has a strategy to change this and…
ATTD Conference Brings World-Renowned Minds to Berlin, Germany
This year’s Advanced Technologies & Treatments for Diabetes (ATTD) meeting, held February 22-25, will have 45 presenters who are or…
